Myeloid Derived Suppressor Cell Quantity prior to Treatment with Ipilimumab as a Biomarker of Overall Survival in Patients with Metastatic Melanoma / Ascierto, Paolo Antonio. - (2012).

Myeloid Derived Suppressor Cell Quantity prior to Treatment with Ipilimumab as a Biomarker of Overall Survival in Patients with Metastatic Melanoma

PAOLO ANTONIO ASCIERTO
2012

2012
Myeloid Derived Suppressor Cell Quantity prior to Treatment with Ipilimumab as a Biomarker of Overall Survival in Patients with Metastatic Melanoma / Ascierto, Paolo Antonio. - (2012).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1042043
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact